Publications by authors named "S Stintzing"

Claim this Profile
I
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Kathrin Heinrich, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani

Eur J Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study.
Katharina Wansch, François Schneider, Florian Dölvers, Anna Kühn, Mihnea P Dragomir, Sebastian Stintzing

Cancer Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
<
Deep Learning-derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-Type Metastatic Colorectal Cancer.
Julius Keyl, René Hosch, Fabian Hörst, Philipp Keyl, Amin Dada, Sebastian Stintzing

Clin Cancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of mismatch repair-deficient tumors].
Sebastian Stintzing, Annabel Alig, Dominik Modest, Ivan Jelas, Arndt Stahler

Inn Med (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients.
François Schneider, Haotian Chen, Uwe Pelzer, Richard G Compton, Gregor Duwe, Sebastian Stintzing

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis